Monitoring drug-induced neurodegeneration by imaging of peripheral benzodiazepine receptors

Annals of the New York Academy of Sciences

Volumn 1025, Issue , 2004, Pages 584-589

  Weissman, Ben Avi ^a   Brandeis, Rachel ^a   Gilat, Eran ^a   Cohen, Giora ^a   Alkalay, David ^a   Rabinovitz, Ishai ^a   Sonego, Hagar ^a   Raveh, Lily ^a  

^a ISRAEL INSTITUTE FOR BIOLOGICAL RESEARCH   (Israel)

Author keywords

3,4 methylenedioxymethamphetamine (MDMA); Behavioral dysfunction; Gliosis; Imaging; Methamphetamine (METH); Neurotoxicity; Peripheral benzodiazepine receptor (PBR); PK 11195

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; BENZODIAZEPINE RECEPTOR; CARAMIPHEN; CARBON 11; COCAINE; METHAMPHETAMINE; MORPHINE; N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE; PYRIDOSTIGMINE; SCOPOLAMINE; SOMAN; TRITIUM;

BEHAVIOR DISORDER; CELL PROLIFERATION; COGNITIVE DEFECT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFERENCE PAPER; GLIA CELL; HUMAN; IN VIVO STUDY; LIGAND BINDING; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; RECEPTOR BINDING;

ANIMALIA;

EID: 10444279250     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1316.072     Document Type: Conference Paper

References (15)

1. HESS, A., C. DESIDERIO & W.G. MCAULIFFE. 1990. Acute neuropathological changes in the caudate nucleus caused by MPTP and methamphetamine: immunohistochemical studies. J. Neurocytol. 19: 338-342.
2. BEITNER-JOHNSON, D., X. GUITART & E.J. NESTLER. 1993 Glial fibrillary acidic protein and the mesolimbic dopamine system: regulation by chronic morphine and Lewis-Fischer strain differences in the rat ventral tegmental area. J. Neurochem. 61: 1766-1773
3. AGUIRRE, N., M. BARRIONUEVO, et al. 1999. Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-induced neurotoxicity. Neuroreport 10: 3675-3680.
4. FATTORE, L., M.C. PUDDU & S. PICCIAU. 2002. Astroglial in vivo response to cocaine in mouse dentate gyms: a quantitative and qualitative analysis by confocal microscopy. Neuroscience 110: 1-6.
5. ZIMMER L.A., M. ENNIS & M.T. SHIPLEY. 1997. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J. Comp. Neurol. 378: 482-492.
6. BENAVIDES, J., D. FAGE, C. CARTER, et al. 1987. Peripheral type benzodiazepine binding sites are a sensitive indirect index of neuronal damage. Brain Res. 421: 167-172.
7. BOLGER, G.T., E. MEZEY, J. COTT, et al. 1984. Differential regulation of central and peripheral benzodiazepine binding sites in the rat olfactory bulb. Eur. J. Pharmacol. 105: 143-148.
8. WEISSMAN, B.A. & L. RAVEH. 2003. Peripheral benzodiazepine receptors: on mice and human brain imaging. J. Neurochem. 84: 432-437.
9. KUHLMANN, A.C. & T.R. GUILARTE. 1997. The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity. Brain Res. 751: 281-288.
10. FILLIAT, P., D. BAUBICHON, M.F. BURCKHART, et al. 1999. Memory impairment after soman intoxication in rat: correlation with central neuropathology. Improvement with anticholinergic and antiglutamatergic therapeutics. Neurotoxicology 20: 535-549.
11. RAVEH, L., B.A. WEISSMAN, G. COHEN, et al. 2002. Caramiphen and scopolamine prevent soman-induced brain damage and cognitive dysfunction. Neurotoxicology 23: 7-17.
12. RAVEH, L., R. BRANDEIS, E. GILAT, et al. 2003. Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction. Toxicol. Sci. 75: 108-116.
13. MCDONOUGH, J.H., JR., R.F. SMITH & C.D. SMITH. 1986. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Toxicol. Teratol. 8: 179-187.
14. LADENHEIM, B., I.N. KRASNOVA, X. DENG, et al. 2000. Methamphetamine- induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Mol. Pharmacol. 58: 1247-1256.
15. PUBILL, D., A.M. CANUDAS, M. PALLAS, et al. 2003. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity. Naunyn Schmiedeberg's Arch. Pharmacol. 367: 490-499.